Tuesday, August 05, 2003

From the Deseret (UT) News:
Drug reimportation too risky
By Sen. Orrin G. Hatch. Hatch is Utah's senior U.S. senator.

From the Deseret (UT) News:
Drugs more costly in U.S. because of FDA process
I ask you which is preferable: a life-saving drug at a high cost or no life-saving drug at all? Americans would be much better served by trying to do something about FDA's costly approval process.

No comments: